Characterisation of glucose transport in Helicobacter pylori.
The nature of the glucose transport system in the bacterium Helicobacter pylori was investigated employing radioactive tracer analysis. Fast D-glucose uptake was demonstrated by using two methods of measuring glucose transport. The transport of 2-deoxy-D-glucose was inhibited competitively by D-glucose; and the efflux of 2-deoxy-D-glucose from cells also was affected by the presence of D-glucose. The transport of 2-deoxy-D-glucose was saturable with a Km of 4.8 mM and Vmax of 146.6 pmol (microliter cell water)-1 at 20 degrees C. The transport was temperature-dependent with energies of activation of 6.8 and 51.0 kJ mol-1 for 0.2 and 20 mM 2-deoxy-D-glucose, respectively. The temperature dependence and saturable nature of transport suggested the presence of one or more glucose carriers. The substrate specificity of the transport system was studied by measuring the effects of mono- and disaccharides on the rates of transport of the glucose analogue. The most significant inhibitory effects were obtained with D-galactose and L-arabinose. Lack of transport inhibition by L-glucose established the stereospecificity of the transporters for the D-isomer of glucose. Higher rates of 2-deoxy-D-glucose transport were measured in the presence of sodium ions than for other monovalent cations, and the presence of amiloride inhibited transport of the monosaccharide. No inhibition was observed with cytochalasin B, phloretin or phloridzin. The results suggested the existence of specific D-glucose transporters and that the glucose transport system of H. pylori is significantly different from other known bacterial transporters.
Mendz
G L
GL
School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney, Australia.
Burns
B P
BP
Hazell
S L
SL
D000584:Amiloride / Q000494:pharmacology; D001089:Arabinose / Q000494:pharmacology; D001692:Biological Transport; D002414:Cations, Monovalent; D003571:Cytochalasin B / Q000494:pharmacology; D003847:Deoxyglucose / Q000378:metabolism*; D005690:Galactose / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D016480:Helicobacter pylori / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D010693:Phloretin / Q000494:pharmacology; D010695:Phlorhizin / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013696:Temperature; D013816:Thermodynamics; D014634:Valinomycin / Q000494:pharmacology
D002414:Cations, Monovalent; D014634:Valinomycin; D003571:Cytochalasin B; D000584:Amiloride; D003847:Deoxyglucose; D012964:Sodium; D001089:Arabinose; D010695:Phlorhizin; D005947:Glucose; D010693:Phloretin; D005690:Galactose